Ginkgo

Factorial Biotechnologies and Ginkgo Bioworks Partner To Develop Enzyme for Single-Cell Library Prep Technology

Retrieved on: 
Monday, September 18, 2023
Tissue, DNA, Business development, Partnership, Enzyme, Therapy, Workflow, NGS, Business, Research, Synthetic biology, Ginkgo Bioworks, SAN, Quality control, Entrepreneurship, Library, NYSE, PCR, Fine chemical, Factorial, Ginkgo

Through this partnership, Factorial will leverage Ginkgo Enzyme Services to develop a novel isothermal DNA polymerase for use in Factorial's single-cell next-generation sequencing (NGS) library prep kit.

Key Points: 
  • Through this partnership, Factorial will leverage Ginkgo Enzyme Services to develop a novel isothermal DNA polymerase for use in Factorial's single-cell next-generation sequencing (NGS) library prep kit.
  • With Factorial's in-cell library prep technology and barcoding scheme, single-cell libraries can also be prepared using digital PCR workflows.
  • To support this promising technology, Ginkgo will lead a campaign in P. pastoris to develop a novel enzyme — isothermal DNA polymerase — instrumental to Factorial's innovative NGS library prep kit.
  • To learn more about Ginkgo Enzyme Services and how you can access Ginkgo's success-based pricing, please visit ginkgobioworks.com/enzyme-services/ .

Exacta Bioscience and Ginkgo Bioworks Announce Partnership to Optimize Exacta's Crop Protection Product

Retrieved on: 
Thursday, August 31, 2023
Wuhan Institute of Biological Products, DNA, Partnership, Farmer, Crop protection, Nutrient, Fermentation, Parimutuel betting, NYSE, Ginkgo, Nature, Ecosystem, Health, Fine chemical, Agriculture

This can lead to overall better crop health, improved yield and increased resistance to stress conditions such as drought or extreme temperatures.

Key Points: 
  • This can lead to overall better crop health, improved yield and increased resistance to stress conditions such as drought or extreme temperatures.
  • Through this partnership, Exacta will use Ginkgo's fermentation and formulation optimization services to reduce the cost of goods to make its FitoRoot technology more competitive.
  • "We chose Ginkgo because their deep expertise in agricultural product development and optimization positions us to make one of our key crop protection products, FitoRoot, more accessible," said José Bustos, CEO at Exacta Bioscience.
  • "Exacta Bioscience's emphasis on microbial solutions in crop health brings more sustainable and differentiated solutions to farmers throughout the Americas," said Magalie Guilhabert, Head of Ag Biologicals, Ginkgo Bioworks.

Ginkgo Bioworks and Google Cloud Partner to Build Next Generation AI Platform for Biological Engineering and Biosecurity

Retrieved on: 
Tuesday, August 29, 2023
Cloud, Intelligence, Centers for Disease Control and Prevention, LLM, DNA, Intellectual property, TPU, Partnership, DARPA, Intelligence Advanced Research Projects Activity, Therapy, Codebase, Global Initiative, SARS-CoV-2, Biogen, Enterprise search, Agriculture, Biotechnology, Synthetic media, COVID-19, Concentric objects, Google Cloud Platform, Public, Sumitomo Chemical, Research, Genomics, Synthetic biology, Government, CDC, Cloud computing, BigQuery, Protein, Moscone Center, Collection, Machine learning, Google Cloud, Engineering, Novo Nordisk, Tensor, Stockholm Environment Institute US Center, Foundry, Drug discovery, Biology, Merck, AI, Ecosystem, GISAID, NYSE, IARPA, Mobile phone, Satellite navigation device, Video game, Network equipment provider, Syngenta, Bayer, Ginkgo

Ginkgo intends to make Google Cloud its primary cloud services provider, significantly increasing its next-generation cloud computing resources, positioning Ginkgo and its customers well as the need for cloud computing expands.

Key Points: 
  • Ginkgo intends to make Google Cloud its primary cloud services provider, significantly increasing its next-generation cloud computing resources, positioning Ginkgo and its customers well as the need for cloud computing expands.
  • "We believe that by partnering with Google Cloud, Ginkgo can supercharge our mission to make biology easier to engineer," said Jason Kelly, co-founder and CEO of Ginkgo Bioworks.
  • Ginkgo operates as a horizontal biological engineering and biosecurity platform, working to accelerate and de-risk scientific R&D projects for customers across industries.
  • Ginkgo and Google Cloud anticipate fueling a number of new Ginkgo offerings and initiatives through the collaboration, including:
    Large language models for biological engineering: Ginkgo plans to leverage Google Cloud's Vertex AI platform and Ginkgo's expansive Codebase to build and train novel foundation and task-specific models for core biological engineering challenges, supported by Google Cloud Consulting .

Concentric by Ginkgo and CGIAR International Livestock Research Institute (ILRI) announce collaboration on pathogen surveillance

Retrieved on: 
Thursday, August 24, 2023
DNA, Poverty, Private sector, Partnership, Food, Biosecurity, Appolinaire Djikeng, Concentric objects, Infection, Livestock, Research, International agricultural research, ILRI, Animal, Ginkgo Bioworks, Ginkgo, Developed country, International Livestock Research Institute, Acceleration, PA Consulting Group, NYSE, CGIAR, Vaccine

BOSTON and NAIROBI, Kenya, Aug. 24, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading horizontal platform for cell programming and biosecurity, and the International Livestock Research Institute (ILRI), a leading organization on One Health approaches, today announced that they have entered into a Memorandum of Understanding with the intent to collaborate on pandemic surveillance work.

Key Points: 
  • The Consultative Group on International Agricultural Research (CGIAR) is a global research partnership for a food-secure future dedicated to transforming food, land, and water systems in the climate crisis.
  • Through its ILRI research institute, CGIAR works to improve food and nutritional security and reduce poverty in developing countries while ensuring better lives through livestock cultivation.
  • ILRI plans to work closely with Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, to identify and mitigate pathogens and diseases that originate in animals and livestock.
  • "ILRI plays a pivotal role in pathogen surveillance, employing a One Health approach in collaboration with a wide range of partners.

Empress Therapeutics Appoints Dawn Thompson, Ph.D., Senior Vice President, Head of Platform Development

Retrieved on: 
Wednesday, August 16, 2023
Health, Technology, Genetics, Research, Artificial Intelligence, Science, DNA, Broad Institute, Microbiology, Therapy, Senior, University, Harvard University, Electronics, Head, RNA-Seq, Agriculture, Genomics, Automation, Genetic code, Associate, Chemistry, Publication, Flagship Pioneering, Engineering, Emperor, Biology, Entrepreneurship, AI, Ginkgo, Next Generation, University of New Hampshire, Synthetic biology, Antibiotics

Empress Therapeutics , a company accelerating small molecule drug generation through novel insights linking genes to chemistry, today announced that Dawn Thompson, Ph.D., has been appointed Senior Vice President, Head of Platform Development.

Key Points: 
  • Empress Therapeutics , a company accelerating small molecule drug generation through novel insights linking genes to chemistry, today announced that Dawn Thompson, Ph.D., has been appointed Senior Vice President, Head of Platform Development.
  • At Gingko, she also oversaw platform development for engineering of novel organism factories to deliver products across diverse commercial applications and markets including pharmaceuticals, living medicines, agriculture, and electronics.
  • At the Broad, Dr. Thompson was concurrently a Senior Group Leader in Evolutionary Genomics.
  • Dr. Thompson was a postdoctoral fellow at Harvard University and received her Ph.D. from the University of Oregon and her B.S.

LAC Taut(R) Radiance+ Premium Collagen Mask and LAC(R) BrainSpeed: Supplements That Work for The Busy Women

Retrieved on: 
Tuesday, July 18, 2023
Forgetting, Skin, Woman, Hyaluronic acid, Brain, Vitamin B3, Ginkgo, Work, Blood, Health, Family, LAC, Antioxidant, Nursing, Dietary supplement

Maintaining better health from the inside out should be the priority of a busy woman, and it should not be a time-consuming, cumbersome process.

Key Points: 
  • Maintaining better health from the inside out should be the priority of a busy woman, and it should not be a time-consuming, cumbersome process.
  • LAC, the Leader in Antioxidative Control(TM), introduces its LAC Taut(R) Radiance+ Premium Collagen Mask and LAC(R) BrainSpeed.
  • The LAC Taut(R) Radiance+ Premium Collagen Mask is not only a luxurious and high-intensity treat for tired, dehydrated skin, its premium collagen-enriched essence is set to rejuvenate skin textures within a mere seven to ten minutes.
  • Specially formulated with a unique and concentrated blend of hydrolyzed collagen, squalane, hyaluronic acid and antioxidants, skin instantly feels velvety smooth, supple and lifted.

Ginkgo Bioworks Announces Date of Second Quarter 2023 Results Presentation

Retrieved on: 
Wednesday, August 2, 2023
DNA, Ginkgo, Q&A, NYSE, Online shopping

BOSTON, Aug. 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2023, on Wednesday, August 9, 2023, beginning at 5:30 p.m. ET.

Key Points: 
  • Presentation and Q&A session scheduled for post-market on Wednesday, August 9, 2023
    BOSTON, Aug. 2, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2023, on Wednesday, August 9, 2023, beginning at 5:30 p.m.
  • ET.
  • The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
  • To ask a question ahead of the presentation, please submit them to @ Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to [email protected] .

Ginkgo Bioworks and Sumitomo Chemical Announce Expanded Partnership To Develop Functional Chemicals with Synthetic Biology

Retrieved on: 
Tuesday, July 18, 2023
DNA, Partnership, Agriculture, Biotechnology, Fermentation, Cosmetics, Sumitomo Chemical, Attention, Carbon, Synthetic biology, Chemical industry, Ginkgo Bioworks, Ginkgo, NYSE, Pharmaceutical industry, Fine chemical

TOKYO and BOSTON, July 18, 2023 /PRNewswire/ -- Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies' existing biomanufacturing partnership.

Key Points: 
  • TOKYO and BOSTON, July 18, 2023 /PRNewswire/ -- Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies' existing biomanufacturing partnership.
  • Sumitomo Chemical and Ginkgo Bioworks have been collaborating since 2021 using Ginkgo's synthetic biology platform for the production of products in industries ranging from personal care and cosmetics, to agriculture and pharma.
  • Today's announcement marks the start of a third project between the companies which aims to enable the mass production of functional chemicals via fermentation.
  • "Sumitomo Chemical is a valued long-term partner to Ginkgo Bioworks, and we are as excited as ever about our work together to introduce bio-based products across multiple industries.

Ginkgo Bioworks and the Ministry of Health of the Republic of Botswana Announce Pathogen Monitoring Program at Key Ports of Entry

Retrieved on: 
Monday, July 17, 2023
DNA, Biosecurity, GBE, SARS-CoV-2, Public, MOH, Biotechnology, Concentric objects, Livestock, Global health, Government, Ministry, International airport, Republic, Ginkgo Bioworks, Ginkgo, MOU, Ministry of Health (Saudi Arabia), NYSE, Vaccine

BOSTON and GABORONE, Botswana, July 17, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Ministry of Health ("MoH") representing the Government of the Republic of Botswana today announced a pathogen monitoring program at key ports of entry to identify new and emerging variants of SARS-CoV-2.

Key Points: 
  • BOSTON and GABORONE, Botswana, July 17, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Ministry of Health ("MoH") representing the Government of the Republic of Botswana today announced a pathogen monitoring program at key ports of entry to identify new and emerging variants of SARS-CoV-2.
  • The program builds on Ginkgo's previously announced MOU to develop and implement biosecurity capabilities in Botswana, and will also incorporate pathogen monitoring at land borders, at municipal wastewater treatment works, and for livestock in the food system.
  • This program is built upon a shared recognition by Concentric and the Botswana MoH of the importance of international collaboration and cooperation to promote global health security.
  • Effective pathogen monitoring and data sharing capabilities can empower government officials, community leaders, and other stakeholders to make informed public health decisions.

IARPA Awards B24IC Research Contract to Ginkgo Bioworks to Develop Breakthrough Biointelligence and Biosecurity Innovations

Retrieved on: 
Thursday, July 13, 2023
Intelligence, DNA, Partnership, ODNI, Intelligence Advanced Research Projects Activity, Genetic engineering, Biosecurity, Biotechnology, Unitary state, Record, Research, Gene expression, United States Intelligence Community, History, College of Engineering (KNUST), Federal government of the United States, Government, Ginkgo, Social policy of the Joe Biden administration, Engineering, IARPA, Growth, NYSE, Genome, Executive order, Mobile phone

Through this program, Ginkgo aims to develop a biosensor that records time-ordered cellular memory for improved traceability and biosecurity.

Key Points: 
  • Through this program, Ginkgo aims to develop a biosensor that records time-ordered cellular memory for improved traceability and biosecurity.
  • "B24IC could boost our approach to biointelligence and biosecurity far beyond our current understanding—years or decades into the future."
  • This announcement deepens Ginkgo's partnership with IARPA to boost the nation's approach to biointelligence and biosecurity.
  • At Ginkgo, we're excited to develop biosecurity innovations that have the potential to both keep us safe and drive innovation in responsible bioengineering."